Product profile
Co-Depricap
Olanzapine + Fluoxetine
Product overview
Regulatory-friendly overview of dosage forms and commercial presentations.
This page summarizes the current product entry from the supplied catalogue source.
Active ingredient
Olanzapine + Fluoxetine
Therapeutic area
CNS
Available dosage forms
Capsule
Available strengths
3/25mg; 6/25mg; 12/25mg
Pack sizes
14’s
Presentations
1
Regulatory note
This catalogue is informational only. Pricing, promotional claims, and market-specific availability are not shown.
Catalogue access
Need the complete portfolio? Download the source file used for this catalogue.
Commercial presentations
Co-Depricap
Available strengths and pack sizes are listed below exactly as provided in the source file.
| Therapeutic area | Generic | Dosage form | Strength | Pack size |
|---|---|---|---|---|
| CNS | Olanzapine + Fluoxetine | Capsule | 3/25mg; 6/25mg; 12/25mg | 14’s |